NCT01409681 A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer Status TERMINATED Phase N/A
NCT01407822 Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT01405079 Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation Status UNKNOWN Phase PHASE3
NCT01404260 Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01401907 Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies Status COMPLETED Phase NA
NCT01401192 Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression Status UNKNOWN Phase PHASE2
NCT01398124 Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung Cancer Status WITHDRAWN Phase NA
NCT01395914 Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3) Status COMPLETED Phase PHASE3
NCT01393080 Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC Patients Status UNKNOWN Phase NA
NCT01391260 Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE2
NCT01387282 Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2) Status COMPLETED Phase PHASE3
NCT01387269 Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1) Status COMPLETED Phase PHASE3
NCT01380769 A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01364012 A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy Status COMPLETED Phase PHASE3
NCT01360554 ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01356368 Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01355497 Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum Status COMPLETED Phase PHASE3